- Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
- Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
- Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
- Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
- Bruker Announces Closing of Chemspeed Technologies AG Acquisition
- Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
- Bruker Corporation to Present at Upcoming Investor Conferences
- Bruker Announces Quarterly Dividend
- Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
- Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
More ▼
Key statistics
As of last trade Bruker Corp (BRKR:NSQ) traded at 82.94, -12.57% below its 52-week high of 94.86, set on Mar 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | 79.49 |
Offer | 81.00 |
Previous close | 82.94 |
Average volume | 587.59k |
---|---|
Shares outstanding | 137.67m |
Free float | 89.95m |
P/E (TTM) | 28.52 |
Market cap | 11.42bn USD |
EPS (TTM) | 2.91 USD |
Annual div (ADY) | 0.20 USD |
---|---|
Annual div yield (ADY) | 0.24% |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Data delayed at least 15 minutes, as of Apr 17 2024 21:00 BST.
More ▼